ACTRN12609001045202招募中2 期
An evaluation of the safety and efficacy of intracoronary selected CD 133+ bone marrow stem cells in cardiac recovery after acute myocardial infarct and left ventricular dysfunction: COMPARE-AMI a randomized controlled double blind clinical study
Miltenyi Biotech Inc.0 个研究点目标入组 40 人开始时间: 2009年12月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 30 Years 至 75 Years（—）
- 性别
- All
入选标准
- •acute ST-elevation myocardial infarct successfully reperfused by means of coronary stent implantation and demonstrated a substantial persistent LV dysfunction defined by a LVEF <50% but >25% on echocardiography obtained within 48 hours after the successful reperfusion therapy.
排除标准
- •known previous myocardial infarct, cardiogenic shock, chronic cardiomyopathy, liver disease, renal failure, concomitant disease with a life expectancy of less than 1 year, alcohol or drug dependency, contraindication for bone marrow (BM) aspiration, blood transfusion in the previous 24 hours, hematopoietic disease, chronic inflammatory disease, malignancy, stroke in the previous 3 months or transient ischemic attack in the previous 24 hours.
研究者
相似试验
尚未招募
2 期
Comparison of safety and efficacy of chemical method vs mechanical method in inducing labour pains in a term pregnant motherCTRI/2020/08/027093Dr Maya menon
尚未招募
4 期
comparing the efficacy and safety ofintralesional acyclovir in two concentration in common wartsCTRI/2024/02/063057Dr RPGMC Kangra at Tanda
已完成
不适用
usefulness of IPL in treating melasmaCTRI/2017/08/009529IPGMER and SSKM HOSPITA32
招募中
不适用
Investigations on the efficacy and safety of intradermal injection of botulinum toxiDiseases of the skin and subcutaneous tissueKCT0004952Samsung Medical Center23
撤回
3 期
Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack (RESUS-AMI)acute myocardial infarction with LVEF< 30%heart attack with heartfailure10011082NL-OMON40846niversity college Cork, Centre for Research in Vascular Biology Bio Sciences Institute15